SCHEMBL3014028

SCHEMBL3014028

CCCCCC(C)C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28695900 0.97 TSHR (0.48)
SCHEMBL31338794 0.97 TSHR (0.48)
SCHEMBL20725833 0.97 TSHR (0.48)
SCHEMBL5495726 0.97 TSHR (0.48)
SCHEMBL9787863 0.97 TSHR (0.48)
SCHEMBL25252646 0.97 TSHR (0.48)
SCHEMBL196200 0.97 TSHR (0.48)
SCHEMBL22263515 0.97 TSHR (0.48)
SCHEMBL663207 0.97 TSHR (0.48)
SCHEMBL15638673 0.97 TSHR (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166149-B Compounds for the treatment of type II diabetes 尼奥比奥特克有限责任公司 2024-02-23 CN claimed
EP-3860989-B1 FUSED PYRROLINES WHICH ACT AS UBIQUITIN-SPECIFIC PROTEASE 30 (USP30) INHIBITORS FORMA THERAPEUTICS INC (US) 2023-04-05 EP claimed
CN-114269323-A Hydrophilic linkers for multivalent peptide conjugates 瓦利托尔有限公司 2022-04-01 CN claimed
CN-113166149-A Compounds for the treatment of type II diabetes 尼奥比奥特克有限责任公司 2021-07-23 CN claimed
US-20200291355-A1 ENGINEERED ERYTHROID CELLS INCLUDING LOADABLE ANTIGEN-PRESENTING POLYPEPTIDES AND METHODS OF USE RUBIUS THERAPEUTICS, INC. 2020-09-17 US claimed
CN-111378137-A Force-induced responsive polymer with multi-network structure 翁秋梅 2020-07-07 CN claimed
CN-107137387-B Synthetic method of aryl propionic acid non-steroidal anti-inflammatory drug 中国科学技术大学 2020-05-12 CN claimed
CN-111093712-A Bioconjugates with controlled degree of conjugation, process for their preparation and reagents for their preparation 国家科学研究中心 2020-05-01 CN claimed
CN-111040204-A Force-induced response dynamic polymer and application thereof 翁秋梅 2020-04-21 CN claimed
CN-111040110-A Force-induced response dynamic polymer and application thereof 翁秋梅 2020-04-21 CN claimed
WO-2020067930-A1 COMPOUNDS FOR TREATING TYPE 2 DIABETES Общество с ограниченной ответственностью "Необиотек" 2020-04-02 WO claimed
EP-3085703-A1 Use of thiol-containing scavengers for purification of antibody-drug conjugates Lonza Ltd (CH) 2016-10-26 EP claimed
WO-2008077809-A1 PROCESS FOR THE MANUFACTURE OF 7-OXA-BICYCLO DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2008-07-03 WO claimed
US-20030049807-A1 Micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities INSTITUTO BIOCHIMICO ITALIANO GIOVANNI LOREZINI S.P.A. (IT) 2003-03-13 US claimed
EP-1291435-A2 A micro-organism possessing enantioselective and regioselective nitrile hydratase/amidase activities ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. (IT) 2003-03-12 EP claimed
EP-0330529-B1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 2-ARYL-PROPIONIC ACIDS RHONE-POULENC SANTE (FR) 1993-03-31 EP claimed
US-5089405-A Hydrolysis of racemic 2-arylpropionamides RHONE-POULENC SANTE (FR) 1992-02-18 US claimed
JP-61165358-A None JP disclosed
US-3948858-A INITIATOR OF 1,2-DIARYL-1,2-CYANO-1,2-DIHALOETHANE AKZO N.V. (NL) 1976-04-06 US disclosed
US-3932678-A Novel dihydrochalcone sweetener compositions THE PROCTER & GAMBLE COMPANY (US) 1976-01-13 US disclosed